Yeah! Another to watch for is MYMX. If this microcap @.02 is able to attract Astellas Pharma, Sanofi(currently). Why not NVAX??? Although, Sanofi just acquired Protein Sciences for their cell-based VLP platform. What's NVAX's chance? A BP partnership in 2018 would be great!